A report will be provided with the patient´s sensitivity/ resistance profile to each of the IMSs tested distributed in one of these categories: very resistant, resistant, undefined, sensitive or very sensitive.
Results are obtained by clusterization (very resistant, resistant, undefined, sensitive or very sensitive) and the categories correlate with clinical outcomes. These categories clusterize patients very well under a semi-quantitative method, including the result of the bioassay and some common clinical data. The IMMUNOBIOGRAM® is NOT, for example, like measuring glucose, it is more of a combination of several variables to cluster patients in the way that best correlates with clinical outcomes.
